Ocular Therapeutix, Inc. (OCUL) Stock Overview
Explore Ocular Therapeutix, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Ocular Therapeutix, Inc. (OCUL)
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
-7.27
EPS (TTM)
$-1.44
ROE
-0.65%
OCUL Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Ocular Therapeutix, Inc. (OCUL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.61.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.27 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.